Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$45.7 - $81.86 $2.3 Million - $4.12 Million
-50,373 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$52.6 - $63.29 $2.62 Million - $3.15 Million
49,721 Added 7625.92%
50,373 $2.65 Million
Q4 2018

Feb 13, 2019

BUY
$31.54 - $46.67 $2,113 - $3,126
67 Added 11.45%
652 $26,000
Q3 2018

Nov 13, 2018

SELL
$38.0 - $51.1 $8,322 - $11,190
-219 Reduced 27.24%
585 $22,000
Q2 2018

Aug 13, 2018

SELL
$38.7 - $50.15 $193 - $250
-5 Reduced 0.62%
804 $36,000
Q1 2018

May 14, 2018

BUY
$39.6 - $65.9 $32,036 - $53,313
809 New
809 $39,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.